In acral melanoma (AM) cases, ulceration was identified to be an independent negative prognostic factor but the impact differed across Breslow thicknesses and clinical stages.
Publications
Bladder tumour as a first manifestation of metastatic choroid melanoma
Incidence of melanoma has been increasing, being able to metastasize to any organ with variable clinical presentation and evolution.
FDA grants priority review to tebentafusp for metastatic uveal melanoma
Tebentafusp-tebn (Kimmtrak, Immunocore) — the only FDA-approved treatment for this indication — is the first T-cell receptor therapeutic to receive regulatory approval.
FDA Approves Tebentafusp-tebn for Unresectable or Metastatic Uveal Melanoma
The FDA has approved tebentafusp-tebn (Kimmtrak) for the treatment of HLA-A*02:01–positive adult patients with unresectable or metastatic uveal melanoma.